Therapist Guided Internet Cognitive Behavioral Therapy (ICBT) for Insomnia for Bereaved Parents: a Randomized Controlled Trial (RCT)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Insomnia
- Sponsor
- Ersta Sköndal University College
- Enrollment
- 21
- Primary Endpoint
- Change (from baseline) in Insomnia Severity Index, ISI
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
The purpose of this project is to evaluate an Internet-based Cognitive Behavioral Therapy (ICBT) for bereaved parents with insomnia. Participants are randomized to either a therapist guided ICBT or to an active control who receives written information on sleep, insomnia, and sleep hygiene. The primary purpose is to evaluate changes in insomnia severity for treatment compared control, after treatment and at 9 and 18 months follow up. A secondary purpose is to evaluate changes in symptoms of complicated grief and depression.
Investigators
Josefin Sveen
PhD
Ersta Sköndal University College
Eligibility Criteria
Inclusion Criteria
- •Clinical level of Insomnia (more than 10 on ISI)
- •Meets criteria for Insomnia according to DSM-5
- •Enough Swedish language skills
Exclusion Criteria
- •Other sleep disorders that require other treatment (e.g. sleep apnea)
- •Somatic or psychiatric conditions requiring acute care
Outcomes
Primary Outcomes
Change (from baseline) in Insomnia Severity Index, ISI
Time Frame: 0, 9 and 18 months after treatment
7-item, self-rated questionnaire measuring change in insomnia severity.
Secondary Outcomes
- Change (from baseline) in Generalised Anxiety Disorder Assessment, GAD-7(0, 9 and 18 months after treatment)
- Change (from baseline) in PTSD Checklist for DSM-5 , PCL-5(0, 9 and 18 months after treatment)
- Change (from baseline) in Montgomery Asberg Depression Rating Scale, MADRS-S(0, 9 and 18 months after treatment)
- Change (from baseline) in Prolonged Grief Disorder, PG-13(0, 9 and 18 months after treatment)
- Change (from baseline) in Utrecht Grief Rumination Scale, UGRS(0, 9 and 18 months after treatment)